-
Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
25 Apr 2024 10:06 GMT
… , particularly in non-small cell lung cancer. Data regarding the prognostic and … ); CheckMate 214: nivolumab-ipilimumab vs sunitinib). LIPI was calculated based on … .55, p < 0.0001; sunitinib: OS LIPI good vs int …
-
Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
22 Jan 2024 22:20 GMT
… seeing sustained benefits over sunitinib in the primary … node positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non–small cell lung cancer, …
-
Everolimus by Novartis for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
18 Apr 2024 03:41 GMT
… ) after failure of treatment with sunitinib or sorafenib, adults with renal … , glioblastoma multiforme, non-small cell lung cancer, myeloblastic syndrome, metastatic colorectal cancer …
-
Toripalimab Combo Receives Chinese Approval for Advanced RCC
10 Apr 2024 21:48 GMT
… in the combination arm vs sunitinib (Sutent) monotherapy at 9.8 … , and non–small cell lung cancer.
“Thank you to all … Toripalimab plus axitinib versus sunitinib as first-line treatment … combination with axitinib versus sunitinib monotherapy in advanced renal …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises … chemotherapy for small cell lung cancer. Lung Cancer. 2006;52(3 … sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108– …
-
Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer
09 Apr 2024 16:44 GMT
… among women and has surpassed lung cancer as the most commonly diagnosed … . Application of clinical bioinformatics in lung cancer-specific biomarkers. Cancer Metastasis Rev … factor 2) causes cardiotoxicity of sunitinib. Autophagy. 2021:1–22. doi …
-
Preparation and Evaluation of Chitosan Coated PLGA Nanoparticles Encapsulating Ivosidenib with Enhanced Cytotoxicity Against Human Liver Cancer Cells
09 Apr 2024 06:51 GMT
… with magnified cytotoxicity against A549 lung cancer cell lines. Saudi J Biol … . Boosting the anticancer activity of sunitinib malate in breast cancer through … for improving anticancer activities against lung cancer cells. Int J Mol Sci …
-
LENVIMA Plus KEYTRUDA Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib
26 May 2023 11:04 GMT
… meaningful OS benefit
versus sunitinib, reducing the risk of … the
superior results versus sunitinib from the primary OS … and ORR
compared to sunitinib. These findings reinforce the … hepatocellular carcinoma, non-small cell lung cancer, RCC,
head and neck …
-
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
25 May 2023 21:35 GMT
… carcinoma, non-small cell lung cancer, RCC, head and neck … KEYTRUDA plus LENVIMA versus sunitinib. Interpretation OS in favorable … resection.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … nonsquamous non-small cell lung cancer (NSCLC), with no …
-
Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
26 May 2022 21:17 GMT
… demonstrated deeper responses vs sunitinib. Regardless of treatment, … non-small cell lung cancer (NSCLC)
Lung cancer is one of … of lung cancer - NSCLC and SCLC (small cell lung cancer). … Organization: GLOBOCAN 2020 – Lung Cancer: Estimated cancer incidence, …